Please login to the form below

Not currently logged in
Email:
Password:

Stephen MacMillan resigns as Stryker’s chair, president and CEO

Curt Hartman takes over as interim CEO and William Parfet steps in as non-executive chairman at the US medical technology firm

Stephen MacMillan has resigned from his roles as chair, president and CEO of Stryker Corporation.

The US-based medical technology firm cited family reasons as the motivation for the departure of MacMillan, who had been chair for two years, CEO for seven years and president for nine years.

MacMillan said: "It has been an enormous privilege to have led Stryker during this period of important change and growth.

“As I look ahead to the next chapter in my life, I remain confident that the team will continue to execute Stryker's strategy with distinction and that the company will enjoy continued success in the future."

Replacing MacMillan as interim CEO is Stryker's current chief financial officer, Curt Hartman, while lead independent director William Parfet will take over as non-executive chairman.

Hartman, who has been with the company since 1990, has served as chief financial officer and vice president since 2009 and his previous roles include holding the post of global president of Stryker Instruments.

Parfet has been a director at Stryker for almost 20 years alongside his role as chair and CEO of drug safety and pharmaceutical development company MPI Research.

15th February 2012

Share

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

Tree
Pharma’s vital role in sustainability and corporate social responsibility
Pharma is in the spotlight as tough questions about sustainability commitments continue to arise...
Infographic: Therapy Watch Hyperlipidaemia
Our latest infographic offers an introduction to the real-world insights collected by our Hyperlipidaemia study....
Article: The rise of the healthcare influencer
In our latest article for Pharmaphorum Deep Dive, we explore the opportunities and benefits for healthcare companies in the online influencer space....